Ripasudil–Brimonidine Fixed-Dose Combination vs Ripasudil or Brimonidine: Two Phase 3 Randomized Clinical Trials-Reference-Cited by-同舟云学术

Ripasudil–Brimonidine Fixed-Dose Combination vs Ripasudil or Brimonidine: Two Phase 3 Randomized Clinical Trials

Published:2023-04 Issue: Volume:248 Page:35-44
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Tanihara Hidenobu,Yamamoto Tetsuya^ORCID,Aihara Makoto^ORCID,Kawakita Koji,Kojima Satoshi,Kanazawa Mizuho,Nojima Toshiaki^ORCID,Suganami Hideki^ORCID

Funder

Kowa Company Ltd

Publisher

Elsevier BV

Subject

Ophthalmology

Reference25 articles.

1. The Japan Glaucoma Society. guidelines for glaucoma (5th edition);J Jpn Ophthalmol Soc,2022

2. American Academy of Ophthalmology. Primary open-angle glaucoma preferred practice pattern 2020. Accessed June 7, 2022. https://www.aao.org/preferred-practice-pattern/primary-open-angle-glaucoma-ppp.

3. Terminology and guidelines for glaucoma,2022

4. Compliance in patients prescribed eyedrops for glaucoma;Patel;Ophthalmic Surg,1995

5. A comprehensive perspective on patient adherence to topical glaucoma therapy;Tsai;Ophthalmology,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Double-Masked, Vehicle-Controlled, Randomized, Phase II Study of the Ocular Hypotensive Activity and Safety of VVN539 Ophthalmic Solution;Ophthalmology Science;2024-03

2. ROCK Inhibitors in Corneal Diseases and Glaucoma—A Comprehensive Review of These Emerging Drugs;Journal of Clinical Medicine;2023-10-25

3. Rho-Kinase Inhibitors as Emerging Targets for Glaucoma Therapy;Ophthalmology and Therapy;2023-10-14

4. Rho-Kinase Inhibitors as Emerging Targets for Glaucoma Therapy;OPHTHALMOL THER;2023

5. Crossover Randomized Study of Pharmacologic Effects of Ripasudil–Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine;Advances in Therapy;2023-06-18